Article Abstract

The reimbursement system is not the dominant factor influencing reluctance to perform single-fraction radiotherapy for painful bone metastases

Authors: Naoki Nakamura, Naoto Shikama


Numerous prospective randomized controlled trials (RCTs) have demonstrated the equivalence of single-fraction (SF) and multi-fraction (MF) radiotherapy (RT) for the palliation of painful bone metastases (1-9). Recent practice guidelines support the use of SF-RT (10-13).